Abstract: . . .  Vaekstfonden, 2004, The Danish Venture Market: Investments and Expectations 4th Quarter 2003 (In Danish). Ernst & Young, 2003, Endurance: Ernst & Young’s 10th Annual European Biotechnology Report 2003. Ingeniøren , various issues (website: www.ing.dk). OECD, 2003, Statistical Definition of Biotechnology , Fourth Ad Hoc Meeting on Biotechnology Statistics. Vækstfonden, 2003, The Danish Market for Venture Capital and Private Equity (2003) (In Danish).  . . .
. . .  Biotechnology in Denmark: A Preliminary Report Carter Bloch The Danish Centre for Studies in Research and Research Policy Working paper 2004/1 April 2004 The Danish Centre for Studies in Research and Research Policy University of Aarhus Finlandsgade 4 DK-8200 Århus N. Phone () 8942 2394 Fax () 8942 2399 www.cfa.au.dk  . . .
. . .  organizations in Denmark, and 9 percent from the EU. Figure 5.3 Sources of external financing: public biotech R&D, 2002 51% 22% 12% 9% 6% Government Private funds Firms EU Other Page 25 25 Chapter 6. Concluding remarks This report has made a preliminary examination of the biotechnology sector in Denmark, based on data from Danish R&D surveys and a compiled list of biotech firms in Denmark. Here we can summarize some of the main findings. Denmark has experienced strong growth in the number of biotech firms in recent years, with total core biotechnology firms numbering 181 in 2003. . . .
. . .  for Studies in Research and Research Policy, 2003c, R&D Statistics 2002: Research and Development in the Public Sector (In Danish). DVCA and Vaekstfonden, 2004, The Danish Venture Market: Investments and Expectations 4th Quarter 2003 (In Danish). Ernst & Young, 2003, Endurance: Ernst & Young’s 10th Annual European Biotechnology Report 2003. Ingeniøren , various issues (website: www.ing.dk). OECD, 2003, Statistical Definition of Biotechnology , Fourth Ad Hoc Meeting on Biotechnology Statistics. Vækstfonden, 2003, The Danish Market for Venture Capital and Private Equity (2003) (In Danish).  . . .
--3000,4,375,2654,51234